Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.
Celeste Krewson
Advertisement
Articles by Celeste Krewson
In a recent study, vaccination administered during pregnancy was effective against severe lower respiratory tract illness associated with respiratory syncytial virus in infants.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Infection Control Today
1
Beyond the Barnyard: How H5N1 Is Crossing Species—and Borders
2
Veteran Infection Preventionists Chat: What Are the Soft Skills That Make Strong IPs?
3
The Postpandemic IP: From Task-Doer to Systems Leader
4
Motivating Leadership and the Team to Improve Employee Engagement, Reduce Burnout, and Build Career Paths
5
